Acclinate-logo
Talk to Our Team

A medical breach of trust is something that lingers in the minds of Black Americans. From the Tuskegee study to modern mistreatment, the racial landscape, and its repercussions, must be acknowledged and dealt with. Because the underlying issues have not been addressed, distrust is continually a fundamental reason for the lack of minority participation in clinical trials or black doctors serving black communities

Since black doctors typically get their degrees from a white system, a system designed to treat and further the healthcare of white Americans above others, it's just as hard for many of their patients to trust them any more than they do white doctors. Many black doctors have a true heart to serve their communities. Providing them with better resources that reflect their representation of the people they serve would be invaluable. 

As of late, many Black Americans are seeking out medical care from black doctors and healthcare providers. It seems the notions of "black pride" and "buy black" are moving into the medical arena as well. Although this doesn't directly address the intentional hands-off directive of the medical community at large to increase the solidarity of healthcare for all Americans, having more black medical professionals treating more black patients can raise interest for reform because let's face it, healthcare costs. Seeing those dollars go down the road to non-ethnic communities can be a true incentive for change and progress.

Another advantage to encouraging and providing access to more black professionals in healthcare is that they can help patients better understand the risks and benefits concerning clinical trials. Black Americans are grossly distrustful of human trials because of the many historically documented cases of inhumane practices. If patients can understand from their doctors and nurses how clinical trials affect healthcare issues that are more prevalent in black people, then perhaps more would come forward to participate in studies.

The bottom line is always a motivator in corporate America. The medical community is closely intertwined with corporate America. However, the real bottom line is that the medical community has a lot of explaining to do. It must redirect its focus from simply including blacks in a "business as usual" sense in healthcare to focusing on the elements that cause alarm and hesitation when it comes to blacks seeking medical care. Increased participation in valuable clinical trials can help further the cause of a healthier America, including Black America. 

To learn more about how Acclinate increases affective trust with communities of color so they are more likely to participate in clinical trials, request a consultation.

Recent Posts

Diversity Action Planning: 5 Myths About the FDA’s Recent Guidance
4 Min Read

Key Takeaways and Learnings Recent clinical research recommendations reinforce the need for robust and sustained community engagement. The FDA’s recen...

Read More
Traditional Clinical Trial Recruitment Companies: 7 Things They Miss
5 Min Read

Key Takeaways and Learnings Clinical trials fall short when communities of color are underrepresented. Trust and awareness are longstanding obstacles ...

Read More
Challenges of the Traditional Clinical Recruitment Process
4 Min Read

Key Takeaways and Learnings Many historically marginalized communities continue to be excluded from clinical trials. Traditional clinical recruitment ...

Read More
What Is Health Equity and Why Should Clinical Researchers Care?
4 Min Read

The past few years have laid bare many disparities in U.S. healthcare.On average, Black Americans live fewer years than white Americans— commonly due ...

Read More
Why Is Health Equity Important: Impacts on Communities of Color
5 Min Read

There are few people as seemingly healthy as Olympic gold medalists. But when sprinter Tori Bowie died in her home due to complications from childbirt...

Read More
FDA Updates Diversity Action Plan Guidance: What Sponsors Need to Know
4 Min Read

From the content of Diversity Action Plans to the nuances of submission, implementation, and monitoring for inclusive and representative research, the...

Read More
doctor using laptop computer
3 Min Read

Though the life sciences industry has committed to improving diversity in clinical trials, there’s still work to be done. Childhood asthma is a case i...

Read More
Unpacking the Latest FDA Guidance: Diversity in Clinical Trials for Pharma
3 Min Read

Earlier this year, the U.S. Food and Drug Administration updated its guidance document on collecting race and ethnicity data in clinical trials. The d...

Read More
Clinical Trial Recruitment Strategies that Increase Diversity
3 Min Read

Under 2022’s Food and Drug Omnibus Reform Act, clinical trial sponsors are required tosubmit diversity action plans with pivotal drug studies such as ...

Read More